Envoy Medical, Inc. (NASDAQ:COCH) Sees Large Increase in Short Interest

Envoy Medical, Inc. (NASDAQ:COCHGet Free Report) saw a large increase in short interest in October. As of October 31st, there was short interest totalling 46,900 shares, an increase of 6.3% from the October 15th total of 44,100 shares. Based on an average daily trading volume, of 227,800 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.7% of the company’s stock are sold short.

Institutional Trading of Envoy Medical

An institutional investor recently bought a new position in Envoy Medical stock. Virtu Financial LLC purchased a new stake in Envoy Medical, Inc. (NASDAQ:COCHFree Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 14,045 shares of the company’s stock, valued at approximately $55,000. Virtu Financial LLC owned about 0.07% of Envoy Medical at the end of the most recent reporting period. 8.59% of the stock is owned by institutional investors and hedge funds.

Envoy Medical Price Performance

Shares of Envoy Medical stock traded up $0.08 during trading on Tuesday, hitting $2.06. 31,076 shares of the stock were exchanged, compared to its average volume of 204,492. The firm’s 50-day moving average price is $2.76 and its 200 day moving average price is $2.67. Envoy Medical has a 12-month low of $0.78 and a 12-month high of $11.46.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on COCH shares. Brookline Capital Management began coverage on shares of Envoy Medical in a research note on Monday, October 14th. They issued a “buy” rating and a $9.00 price target for the company. Ascendiant Capital Markets upped their price target on Envoy Medical from $8.50 to $8.75 and gave the stock a “buy” rating in a report on Tuesday, September 3rd.

View Our Latest Stock Report on COCH

Envoy Medical Company Profile

(Get Free Report)

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.

See Also

Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.